$ELTP: I listened to the CEO's CC this morning, where he explained the contents of the CRL The FDA had one issue only, and it is somewhat minor. However, this will push approval back months.
Fortunately, I sold 30% of my holdings last Wed, but I bought those shares back at half the price early this morning.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.